Cargando…
Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease
Autores principales: | Grüter, Thomas, Behrendt, Volker, Bien, Corinna I., Gold, Ralf, Ayzenberg, Ilya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320942/ https://www.ncbi.nlm.nih.gov/pubmed/32444985 http://dx.doi.org/10.1007/s00415-020-09924-y |
Ejemplares similares
-
Patients’ IgLON5 autoantibodies interfere with IgLON5-protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
IgLON5 disease responsive to immunotherapy
por: Bonello, Michael, et al.
Publicado: (2017) -
Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions
por: Landa, Jon, et al.
Publicado: (2023) -
Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020) -
Bilateral vestibulopathy in anti-IgLON5 disease
por: Helmchen, Christoph, et al.
Publicado: (2021)